6 ML ublituximab-xiiy 25 MG/ML Injection [Briumvi]
- RxCUI
- 2626359
- RxNorm name
- 6 ML ublituximab-xiiy 25 MG/ML Injection [Briumvi]
- Display name
- 6 ML ublituximab-xiiy 25 MG/ML Injection [Briumvi]
- Full name
- 6 ML ublituximab-xiiy 25 MG/ML Injection [Briumvi]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:54
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761238 | Briumvi | ublituximab-xiiy | 351(a) | Rx | 2026-09-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BRIUMVI | UBLITUXIMAB | TG Therapeutics, Inc. | 3a77cd8c-811b-407c-9140-d0c5c26435c2 | 2026-02-19 | Warnings, Adverse reactions | 2626359 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 3a77cd8c-811b-407c-9140-d0c5c26435c2 | Briumvi 150 MG in 6 ML Injection [PSN] · 6 ML ublituximab-xiiy 25 MG/ML Injection [Briumvi] [SBD] · 6 ML Briumvi 25 MG/ML Injection [SY] · Briumvi 150 MG per 6 ML Injection [SY] | 4 | 21 | These highlights do not include all the information needed to use BRIUMVI safely and effectively. See full prescribing information for BRIUMVI. BRIUMVI ® (ublituximab-xiiy) injection, for intravenous use Initial U.S. Approval: 2022 | 20260219 |